Jonathan Anderman
General Counsel · 2 filings · Latest: Apr 29, 2026
Compass Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
CMPX | Jonathan Anderman | General Counsel | Apr 29, 2026 | Purchase | $1.89 | 25,000 | $47.3K | 196,000 |